|[September 15, 2004]
VisiJet Opens 14 Additional Markets with New EpiLift and LasiTome Systems; Products Shipped Worldwide for Significant Market Penetration and Revenue
IRVINE, Calif. --(Business Wire)-- Sept. 15, 2004 -- VisiJet Inc. (OTCBB:VJET), developers of innovative technologies for the ophthalmic surgical market, announced today that it has opened 14 markets to date with its EpiLift and LasiTome Systems -- next-generation, ophthalmic surgical products used for refractive surgery.
"The growth and market penetration demonstrated by our EpiLift and LasiTome products have been substantial," said Randy Bailey, president and CEO of VisiJet. "This acceleration demonstrates an acceptance of our technologies that will create and sustain successful product lines."
Bailey indicated that the company now ships products to Hong Kong, Germany, Czechoslovakia, Korea, Cyprus, Italy, Russia, Malaysia, Jordan, Romania, the Benelux countries, the United Kingdom, Spain, Greece and Israel. He anticipates expanding distribution even further by the end of this year.
Bailey believes the growth is due to the many advances and benefits offered by the systems. The products solve many of the procedural problems associated with certain refractive surgeries today.
VisiJet signed an agreement earlier this year with Gebauer Medizintechnik GmbH of Neuhausen, Germany, for the worldwide distribution rights to its Epi-LASIK products and has experienced continued revenue increases with the product lines.
ABOUT VISIJET INC.
VisiJet Inc. is a medical device company based in Irvine, focused on the development and marketing of innovative ophthalmic applications that result in faster, safer and more efficacious procedures in two of the largest surgical markets in the world: refractive and cataract surgeries. VisiJet's lead products, the HydroKeratome(R) and Pulsatome(R), utilize the company's proprietary and patented waterjet technology that uses a high-pressure micro beam of water the diameter of a human hair to cut ocular tissue. The FDA-approved HydroKeratome(R) uses the waterjet technology to cut the cornea as required in LASIK surgery. The Pulsatome(R), currently under development, is a device that uses waterjet technology to remove cataracts - the most performed surgical procedure in the world. In addition, the company recently acquired the exclusive worldwide distribution, sales and marketing rights for the LASIK and Epi-LASIK products from Gebauer Medizintechnik GmbH of Neuhausen, Germany. These products, the LasiTome and the EpiLift, improve upon existing technologies with unique separating methods that can eliminate many postoperative problems. VisiJet Inc. is located at 192 Technology Drive, Suite Q, Irvine, CA. Phone: 949-450-1660, Fax: 949-453-9652, Investor Relations: 949-450-1660 ext. 28. Web site: www.visijet.com.
Except for historical information contained herein, the matters discussed in this news release are forward-looking statements within the meaning of the Securities Exchange Act that involve risks and uncertainties that could cause actual results to differ materially from those expressed. These matters include, but are not limited to, the anticipated financing information about the company's technologies and products, financial situations, or business opportunities. This news release shall not constitute an offer to sell or the solicitation of an offer to sell any of these securities.
[ Back To TMCnet.com's Homepage ]